References
- Young EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 5th edn. Philadelphia, PA: Churchill Livingstone; 2000. p. 2386–90.
- Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the brucellosis laboratory. Paris: INRA; 1988.
- Morey NP, Holcomb LA. Brucella. In: Murray PR, Baron EJ, Pfaaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 6th edn. Washington, DC: ASM Press; 1995. p. 549–55.
- Garcia-Rodriguez JA, Garcia Sanchez JE, Trujillano I. Lack of effective bacterial activity of new quinolones against Brucella spp. Antimicrob Agents Chemother 1991; 35: 756–9.
- Gür D, Kocagöz S, Akova M, Ünal S. Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis. Antimicrob Agents Chemother 1999; 43: 2337.
- Rubinstein ER, Lang R, Shasha B, Hagar B, Diamanstein L, Joseph G, et al. In vitro susceptibility of Brucella melitensis to antibiotics. Antimicrob Agents Chemother 1991; 35: 1925–7.
- Trujillano-Martin I, Garcia-Sanchez E, Martinez IM, Fresna-dillo MJ, Garcia-Sanchez JE, Garcia-Rodriguez JA, et al. In vitro activities of six new fluoroquinolones against Brucella melitensis. Antimicrob Agents Chemother 1999; 43: 194–5.
- Akova M, Gür D, Livermore DM, Kocagöz T, Akalin HE. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. Antimicrob Agents Chemother 1999; 43: 1298–300.
- Kocagöz S, Akova M, Altun B, Gür D, Hasçelik G. In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey. Clin Microbiol Infect 2002; 8: 240–2.
- Kinsara A, Al-Mowallad A, Osaba AO. Increasing resistance of Brucellae to co-trimoxazole. Antimicrob Agents Chemother 1999; 43: 1531.
- Qadri SM, Akhtar M, Ueno Y, al-Sabia MB. Susceptibility of Brucella melitensis to fluoroquinolones. Drugs Exp Clin Res 1989; 15: 483–5.